Affinivax

by | Feb 27, 2023 | Historical | 0 comments

Vaccine development platform leveraging technology developed at Boston Children’s Hospital, with lead program for prevention of pneumococcal disease

Submit a Comment

Your email address will not be published. Required fields are marked *